These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 409795)

  • 1. Serum lysozyme in multiple myeloma.
    Deo EA; Brook J
    J Lab Clin Med; 1977 Nov; 90(5):899-903. PubMed ID: 409795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the usefulness of measuring the serum and urine levels of light chain immunoglobulins in multiple myeloma and Waldenström's macroglobulinemia].
    Kraj M; Maj S; Rostkowska J
    Acta Haematol Pol; 1991; 22(1):21-30. PubMed ID: 1823963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution in patients with multiple myeloma or with monoclonal gammopathy of undetermined significance.
    Papadea C; Reimer CB; Check IJ
    Ann Clin Lab Sci; 1989; 19(1):27-37. PubMed ID: 2492788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of multiple myeloma: relation to class and type M component.
    Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):896-7. PubMed ID: 817790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light chain nephropathy: histological and clinical aspects in 15 cases.
    Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
    Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
    Creyssel R; Gibaud A; Cordier JF; Boissel JP
    Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The proportion of kappa and lambda light chains among monotypic IgG and IgA].
    Nikolić V; Dovezenski N; Milosević-Jovcić N
    Srp Arh Celok Lek; 1986; 114(11-12):991-9. PubMed ID: 3109038
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y; Benbassat J; Polliack A
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysozyme in the serum, urine and peripheral blood leukocytes in patients with immunocytoma.
    Kraj M; Krzemińska-Lawkowiczowa I; Lawkowicz W; Krawczyński J; Sawicki Z; Mdzewski B; Cieśluk S; Czartoryska B; Górska D; Dmowska B
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):875-88. PubMed ID: 121534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin isotypes on monoclonal blood lymphocytes in human plasma cell myeloma.
    Pettersson D; Mellstedt H; Holm G
    J Clin Lab Immunol; 1980 Mar; 3(2):93-8. PubMed ID: 6782249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multiple myeloma with double M-protein peaks for IgG-kappa and IgA-kappa].
    Tadao F; Hayashi M; Ichikawa K; Hirasawa Y; Ohtani H; Saito M; Hatimura K; Oshikawa T; Takayama M; Mori N
    Rinsho Ketsueki; 1984 Oct; 25(10):1646-52. PubMed ID: 6441031
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
    King MA; Vivianwells J
    Clin Exp Immunol; 1981 Sep; 45(3):544-51. PubMed ID: 6175454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammapathies.
    Fine JM; Lambin P
    Biomedicine; 1975 Oct; 23(8):323-7. PubMed ID: 821548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical abnormalities in multiple myeloma.
    Choo-Kang E; Campbell M
    West Indian Med J; 1991 Dec; 40(4):170-2. PubMed ID: 1785196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three M-components IgA lambda + IgG kappa n + IgG kappa h in one patient (DA): lack of shared idiotypic determinants between IgA and IgG, and the presence of an unusual kappa h chain of 30,000 M.W.
    Bouvet JP; Liacopoulos P; Pillot J; Banda R; Tung E; Wang AC
    J Immunol; 1980 Jul; 125(1):213-20. PubMed ID: 6769997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.